Yes. At Bristol Myers Squibb Sam owned the enterprise generative-AI portfolio for a global Medical Affairs organization, a production RAG platform serving ~2,000 users across 50+ markets, governed under GxP and 21 CFR Part 11.
Yes. He shipped and governed a production retrieval-augmented generation platform serving ~2,000 users across 50+ markets inside an ~$8M annual GenAI and digital portfolio at Bristol Myers Squibb.
He is hands-on; a technical peer confirmed he worked in the code on retrieval-augmented generation, ranking strategies, agentic workflows, and LLM-as-a-judge evaluation, and his public repos include MCP servers, agent harnesses, and a retrieval-evaluation stack in Python and TypeScript.
Since April 2026, Sam has built a production legal AI agent for an anonymous law practice and a working independent content automation stack covering signal intake, duplicate checks, brand routing, structured authoring, human review, deterministic video rendering, and controlled channel operations. An anonymous client architecture remains in the specification phase. He also built a product evidence selection case study with published evaluation metrics and a clean-room field evidence certification prototype.
He is remote-first, based in the Philadelphia metro (Doylestown, PA), is a US citizen, and needs no sponsorship.